申请人:Eli Lilly and Company
公开号:US06635657B1
公开(公告)日:2003-10-21
This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
本申请涉及式I化合物(或其药用可接受的盐),如本文所述,其药物组合物,及其作为因子Xa抑制剂的用途,以及其制备过程和中间体。